Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension

Clinical trial NCT00380068 · COMPLETED

Trial details

NCT number: NCT00380068
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2006-08-01
Primary completion: 2008-07-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.